Lineage Cell Therapeutics
LCTX
#8976
Rank
โ‚น8.44 B
Marketcap
โ‚น36.96
Share price
3.62%
Change (1 day)
-67.40%
Change (1 year)

EPS for Lineage Cell Therapeutics (LCTX)

EPS in 2023 (TTM): -โ‚น10.67

According to Lineage Cell Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น11.11. In 2022 the company made an earnings per share (EPS) of -โ‚น12.82 an increase over its 2021 EPS that were of -โ‚น22.23.

EPS history for Lineage Cell Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น10.67-16.81%
2022-โ‚น12.82-42.31%
2021-โ‚น22.2385.71%
2020-โ‚น11.97250%
2019-โ‚น3.42-88.57%
2018-โ‚น29.92105.88%
2017-โ‚น14.53-153.13%
2016โ‚น27.35-154.24%
2015-โ‚น50.435.36%
2014-โ‚น47.87-30.86%
2013-โ‚น69.2488.37%
2012-โ‚น36.7619.44%
2011-โ‚น30.7733.33%
2010-โ‚น23.0868.75%
2009-โ‚น13.68-5.88%
2008-โ‚น14.53183.33%
2007-โ‚น5.13-25%
2006-โ‚น6.84-27.27%
2005-โ‚น9.40-38.89%
2004-โ‚น15.3938.46%
2003-โ‚น11.11-43.48%
2002-โ‚น19.66-26.63%
2001-โ‚น26.80-28.75%
2000-โ‚น37.61-13.73%
1999-โ‚น43.60
1997-โ‚น28.213.12%
1996-โ‚น27.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น186.35 1,576.92%๐Ÿ‡บ๐Ÿ‡ธ USA